Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 BMC Neurol
1 Brain
3 Brain Dev
2 Epilepsia
1 Epilepsy Res
3 Epileptic Disord
3 J Child Neurol
1 Neurol Genet
3 Neurology
1 Neuroscience
1 Pediatr Neurol
4 Seizure

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Neurol

  1. WANG M, Yu J, Xiao X, Zhang B, et al
    Changes of biochemical biomarkers in the serum of children with convulsion status epilepticus: a prospective study.
    BMC Neurol. 2022;22:196.
    PubMed         Abstract available


  2. BERNABEI JM, Sinha N, Arnold TC, Conrad E, et al
    Normative intracranial EEG maps epileptogenic tissues in focal epilepsy.
    Brain. 2022 May 31. pii: 6595865. doi: 10.1093.
    PubMed         Abstract available

    Brain Dev

  3. GIACOMINI T, Scala M, Nobile G, Severino M, et al
    De novo POLR2A p.(Ile457Thr) variant associated with early-onset encephalopathy and cerebellar atrophy: expanding the phenotypic spectrum.
    Brain Dev. 2022;44:480-485.
    PubMed         Abstract available

  4. D'ONOFRIO G, Riva A, Di Rosa G, Cali' E, et al
    Paroxysmal limb dystonias associated with GABBR2 pathogenic variant: A case-based literature review.
    Brain Dev. 2022;44:469-473.
    PubMed         Abstract available

  5. KOMATSU K, Fukumura S, Minagawa K, Nakashima M, et al
    A new case of concurrent existence of PRRT2-associated paroxysmal movement disorders with c.649dup variant and 16p11.2 microdeletion syndrome.
    Brain Dev. 2022;44:474-479.
    PubMed         Abstract available


  6. STODBERG T, Tomson T, Anderlid BM, Andersson T, et al
    Outcome at age 7 of epilepsy presenting in the first 2 years of life. A population-based study.
    Epilepsia. 2022 Jun 2. doi: 10.1111/epi.17314.
    PubMed         Abstract available

  7. LI EC, Zheng Y, Cai MT, Lai QL, et al
    Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.
    Epilepsia. 2022 Jun 2. doi: 10.1111/epi.17315.
    PubMed         Abstract available

    Epilepsy Res

  8. ZHANG J, Qiao N, Wang J, Li B, et al
    Nuclear translocation of GluA2/ GAPDH promotes neurotoxicity after pilocarpine-induced epilepsy.
    Epilepsy Res. 2022;183:106945.
    PubMed         Abstract available

    Epileptic Disord

  9. FERNANDEZ-TORRE JL, Hernandez-Hernandez MA, Orizaola P, Paramio-Paz A, et al
    Typical absence status epilepticus in older people: syndromic delineation.
    Epileptic Disord. 2022;24:1-6.
    PubMed         Abstract available

  10. MANGANOTTI P, Furlanis G, Cova MA, Olivo S, et al
    Isolated aphasic status epilepticus: CT perfusion, SPECT and EEG reveal neurovascular coupling and support the differential diagnosis.
    Epileptic Disord. 2022;24:1-6.
    PubMed         Abstract available

  11. KISHIMOTO K, Nabatame S, Kagitani-Shimono K, Kato M, et al
    Ketogenic diet for focal epilepsy with.
    Epileptic Disord. 2022;24:1-3.

    J Child Neurol

  12. DEMAREST S, Marsh R, Treat L, Fisher MP, et al
    The Lived Experience of Parents' Receiving the Diagnosis of CDKL5 Deficiency Disorder for Their Child.
    J Child Neurol. 2022;37:451-460.
    PubMed         Abstract available

  13. ARREDONDO K, Myers C, Hansen-Kiss E, Mathew MT, et al
    Phenotypic Spectrum in a Family Sharing a Heterozygous KCNQ3 Variant.
    J Child Neurol. 2022;37:517-523.
    PubMed         Abstract available

  14. SALDARIS J, Leonard H, Jacoby P, Marsh ED, et al
    Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).
    J Child Neurol. 2022;37:541-547.
    PubMed         Abstract available

    Neurol Genet

  15. Erratum: Multigene Panel Testing in a Large Cohort of Adults With Epilepsy: Diagnostic Yield and Clinically Actionable Genetic Findings.
    Neurol Genet. 2022;8:e674.
    PubMed         Abstract available


  16. TSUJI S
    Broadening Neurologic Manifestations in Adult Patients With Dravet Syndrome.
    Neurology. 2022;98:913-914.

  17. SELVARAJAH A, Gorodetsky C, Marques P, Zulfiqar Ali Q, et al
    Progressive Worsening of Gait and Motor Abnormalities in Older Adults With Dravet Syndrome.
    Neurology. 2022;98:e2204-e2210.
    PubMed         Abstract available

  18. GANGULY TM, Ellis CA, Tu D, Shinohara RT, et al
    Seizure Detection in Continuous Inpatient EEG: A Comparison of Human vs Automated Review.
    Neurology. 2022;98:e2224-e2232.
    PubMed         Abstract available


  19. NAIR KP, Salaka RJ, Srikumar BN, Kutty BM, et al
    Enriched environment rescues impaired sleep-wake architecture and abnormal neural dynamics in chronic epileptic rats.
    Neuroscience. 2022 May 25. pii: S0306-4522(22)00264.
    PubMed         Abstract available

    Pediatr Neurol

  20. TARQUINIO D, Dlugos D, Wheless JW, Desai J, et al
    Safety of Diazepam Nasal Spray in Children and Adolescents With Epilepsy: Results From a Long-Term Phase 3 Safety Study.
    Pediatr Neurol. 2022;132:50-55.
    PubMed         Abstract available


  21. JIN B, Zhang Z, Wang C, Li H, et al
    Focal thalamocortical circuit abnormalities in sleep related epilepsy caused by focal cortical dysplasia type II.
    Seizure. 2022;99:153-158.
    PubMed         Abstract available

  22. NABAVI NOURI M, Puka K, Palmar K, Speechley KN, et al
    Impact of number of anti-seizure medications on long-term health-related quality of life in children with epilepsy: A prospective cohort study.
    Seizure. 2022;99:120-126.
    PubMed         Abstract available

  23. SUN H, Li J, Maimaiti B, Liu J, et al
    Circulating malondialdehyde level in patients with epilepsy: A meta-analysis.
    Seizure. 2022;99:113-119.
    PubMed         Abstract available

  24. CHEN DD, Peng XL, Cheng H, Ma JN, et al
    Risk factors and a predictive model for the development of epilepsy after Japanese encephalitis.
    Seizure. 2022;99:105-112.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.